SAGE Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 88   

Articles published

SAGE 162.37 -1.23 (-0.75%)
price chart
Intelligent Options Trading: Right After Earnings in Sage Therapeutics Inc
The results here are provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation.
Sage Therapeutics Incorporated (NASDAQ:SAGE) Has Increase in Shorts
Baker Bros Advsr L P reported 0.2% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE). Prudential reported 0% in Sage Therapeutics, Inc. (NASDAQ:SAGE). Glob X Ltd owns 0% invested in Sage Therapeutics, Inc. (NASDAQ:SAGE) for 245 shares. Citadel ...
Public Employees Retirement Association of Colorado Invests $506000 in SAGE ...  The Ledger Gazette
Is Sage Therapeutics Incorporated (NASDAQ:SAGE)'s Fuel Running Low ...  Frisco Fastball
Healthcare Stock to Buy: Sage Therapeutics, Inc. (SAGE)
Sage Therapeutics, Inc. (SAGE) stock price moved with dropping change along with the volume 0.47 million shares in Friday trading session.
Commit To Buy Sage Therapeutics At $130, Earn 13.4% Using Options
Investors considering a purchase of Sage Therapeutics Inc (Symbol: SAGE) shares, but cautious about paying the going market price of $189.53/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Sage Therapeutics Inc. (SAGE) Moves Higher on Volume Spike for February 13
Sage Therapeutics Inc. (SAGE) traded on unusually high volume on Feb. 13, as the stock gained 0.48% to close at $160.10. On the day, Sage Therapeutics Inc. saw 1.06 million shares trade hands on 8,698 trades. Considering that the stock averages only a ...
Reviewing the Insider Trends for Sage Therapeutics, Inc. (SAGE)  StockNewsGazette
Sage Therapeutics to Report Fourth Quarter and Full Year 2017 Financial ...  Business Wire (press release)
Stock Review for Biotech's Investors -- Sage Therapeutics, Sarepta ...
Shares in San Diego, California-based Sorrento Therapeutics Inc. finished 3.55% lower at $6.80. The stock recorded a trading volume of 2.72 million shares, which was above its three months average volume of 2.01 million shares.
EPS for Sarepta Therapeutics, Inc. (SRPT) Expected At $-0.35  BZ Weekly
$-0.35 EPS Expected for Sarepta Therapeutics, Inc. (SRPT)  Reurope
Sage Therapeutics Reaches Analyst Target Price
In recent trading, shares of Sage Therapeutics Inc (Symbol: SAGE) have crossed above the average analyst 12-month target price of $179.14, changing hands for $180.53/share.
Sage Therapeutics Inc. (SAGE) Breaks into New 52-Week High on January 23 Session
Price Alert: Sage Therapeutics Inc (NASDAQ:SAGE) Stock Nears Resistance ...
Price Alert: Sage Therapeutics Inc (NASDAQ:SAGE) has now crossed into technical strength -- watch the technical oscillators for momentum gaps.
Can analysts adopt a bullish outlook for Sage Therapeutics, Inc. (NASDAQ:SAGE)?
Picton Mahoney Asset Mgmt stated it has 0.4% in Sage Therapeutics, Inc. (NASDAQ:SAGE). Moreover, State Board Of Administration Of Florida Retirement Sys has 0% invested in Sage Therapeutics, Inc. (NASDAQ:SAGE) for 16,852 shares. Lord Abbett Ltd stated ...
Have Analysts Now Turned Cautious On Sage Therapeutics, Inc. (SAGE), Sprint ...  Post Analyst
Essex Investment Management Co. LLC Lowers Stake in SAGE Therapeutics Inc (SAGE)  The Ledger Gazette
Sage Therapeutics Inc. (SAGE) Plunges 6.39% on February 08
Sage Therapeutics Inc. (SAGE) had a rough trading day for Thursday February 08 as shares tumbled 6.39%, or a loss of $-11.33 per share, to close at $166.05.